The correlation between vitamin D level and liver fibrosis in patients with metabolic dysfunction-associated fatty liver disease
ObjectiveTo investigate the correlation between different forms of serum vitamin D levels and liver fibrosis in patients with metabolic dysfunction-associated fatty liver disease (MAFLD). MethodsData from the National Health and Nutrition Examination Survey in 2021–2023 were analyzed. Logistic regre...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Shanghai Chinese Clinical Medicine Press Co., Ltd.
2025-06-01
|
| Series: | Zhongguo Linchuang Yixue |
| Subjects: | |
| Online Access: | https://www.c-jcm.com/article/doi/10.12025/j.issn.1008-6358.2025.20250074 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849320320950861824 |
|---|---|
| author | Huajuan WANG Shujun SHI Xuelian XIONG |
| author_facet | Huajuan WANG Shujun SHI Xuelian XIONG |
| author_sort | Huajuan WANG |
| collection | DOAJ |
| description | ObjectiveTo investigate the correlation between different forms of serum vitamin D levels and liver fibrosis in patients with metabolic dysfunction-associated fatty liver disease (MAFLD). MethodsData from the National Health and Nutrition Examination Survey in 2021–2023 were analyzed. Logistic regression models were used to evaluate the relationship between serum total vitamin D, 25(OH)D3 levels, and liver fibrosis in the MAFLD patients. ResultsA total of 2 628 patients were included. There were significant differences between MAFLD patients with liver fibrosis and those without fibrosis in age, smoking history, waist circumference, body mass index, high-density lipoprotein cholesterol, total cholesterol, fasting plasma glucose, hypertension history, vitamin D, and 25(OH)D3 levels (P＜0.05). Logistic regression analysis revealed that compared to the low total serum vitamin D group (11.2-61.8 nmol/L), MAFLD patients with high total vitamin D levels (89.1 nmol/L＜vitamin D≤290 nmol/L) exhibited a 22% reduced risk of liver fibrosis (OR＝0.78, 95%CI 0.64-0.94, P＝0.015). Similarly, compared to the low 25(OH)D3 group (4.1-57.0 nmol/L), those with high 25(OH)D3 level [84.7 nmol/L＜25(OH)D3≤288 nmol/L] showed a 23% lower risk of liver fibrosis (OR＝0.77, 95%CI 0.62-0.95, P＝0.021). After adjusting for covariates, high total vitamin D levels remained significantly associated with reduced liver fibrosis risk (OR＝0.63, 95%CI 0.42-0.94, P＝0.036). ConclusionsElevated serum total vitamin D and 25(OH)D3 levels are protective factors against early liver fibrosis in MAFLD patients. |
| format | Article |
| id | doaj-art-348e64ee08e24efbbfd6c262fdcc46ef |
| institution | Kabale University |
| issn | 1008-6358 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Shanghai Chinese Clinical Medicine Press Co., Ltd. |
| record_format | Article |
| series | Zhongguo Linchuang Yixue |
| spelling | doaj-art-348e64ee08e24efbbfd6c262fdcc46ef2025-08-20T03:50:07ZengShanghai Chinese Clinical Medicine Press Co., Ltd.Zhongguo Linchuang Yixue1008-63582025-06-0132332733310.12025/j.issn.1008-6358.2025.2025007420250074The correlation between vitamin D level and liver fibrosis in patients with metabolic dysfunction-associated fatty liver diseaseHuajuan WANG0Shujun SHI1Xuelian XIONG2Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai 200032, ChinaDepartment of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai 200032, ChinaDepartment of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai 200032, ChinaObjectiveTo investigate the correlation between different forms of serum vitamin D levels and liver fibrosis in patients with metabolic dysfunction-associated fatty liver disease (MAFLD). MethodsData from the National Health and Nutrition Examination Survey in 2021–2023 were analyzed. Logistic regression models were used to evaluate the relationship between serum total vitamin D, 25(OH)D3 levels, and liver fibrosis in the MAFLD patients. ResultsA total of 2 628 patients were included. There were significant differences between MAFLD patients with liver fibrosis and those without fibrosis in age, smoking history, waist circumference, body mass index, high-density lipoprotein cholesterol, total cholesterol, fasting plasma glucose, hypertension history, vitamin D, and 25(OH)D3 levels (P＜0.05). Logistic regression analysis revealed that compared to the low total serum vitamin D group (11.2-61.8 nmol/L), MAFLD patients with high total vitamin D levels (89.1 nmol/L＜vitamin D≤290 nmol/L) exhibited a 22% reduced risk of liver fibrosis (OR＝0.78, 95%CI 0.64-0.94, P＝0.015). Similarly, compared to the low 25(OH)D3 group (4.1-57.0 nmol/L), those with high 25(OH)D3 level [84.7 nmol/L＜25(OH)D3≤288 nmol/L] showed a 23% lower risk of liver fibrosis (OR＝0.77, 95%CI 0.62-0.95, P＝0.021). After adjusting for covariates, high total vitamin D levels remained significantly associated with reduced liver fibrosis risk (OR＝0.63, 95%CI 0.42-0.94, P＝0.036). ConclusionsElevated serum total vitamin D and 25(OH)D3 levels are protective factors against early liver fibrosis in MAFLD patients.https://www.c-jcm.com/article/doi/10.12025/j.issn.1008-6358.2025.20250074vitamin dmetabolic dysfunction-associated fatty liver diseaseliver fibrosisnational health and nutrition examination survey database |
| spellingShingle | Huajuan WANG Shujun SHI Xuelian XIONG The correlation between vitamin D level and liver fibrosis in patients with metabolic dysfunction-associated fatty liver disease Zhongguo Linchuang Yixue vitamin d metabolic dysfunction-associated fatty liver disease liver fibrosis national health and nutrition examination survey database |
| title | The correlation between vitamin D level and liver fibrosis in patients with metabolic dysfunction-associated fatty liver disease |
| title_full | The correlation between vitamin D level and liver fibrosis in patients with metabolic dysfunction-associated fatty liver disease |
| title_fullStr | The correlation between vitamin D level and liver fibrosis in patients with metabolic dysfunction-associated fatty liver disease |
| title_full_unstemmed | The correlation between vitamin D level and liver fibrosis in patients with metabolic dysfunction-associated fatty liver disease |
| title_short | The correlation between vitamin D level and liver fibrosis in patients with metabolic dysfunction-associated fatty liver disease |
| title_sort | correlation between vitamin d level and liver fibrosis in patients with metabolic dysfunction associated fatty liver disease |
| topic | vitamin d metabolic dysfunction-associated fatty liver disease liver fibrosis national health and nutrition examination survey database |
| url | https://www.c-jcm.com/article/doi/10.12025/j.issn.1008-6358.2025.20250074 |
| work_keys_str_mv | AT huajuanwang thecorrelationbetweenvitamindlevelandliverfibrosisinpatientswithmetabolicdysfunctionassociatedfattyliverdisease AT shujunshi thecorrelationbetweenvitamindlevelandliverfibrosisinpatientswithmetabolicdysfunctionassociatedfattyliverdisease AT xuelianxiong thecorrelationbetweenvitamindlevelandliverfibrosisinpatientswithmetabolicdysfunctionassociatedfattyliverdisease AT huajuanwang correlationbetweenvitamindlevelandliverfibrosisinpatientswithmetabolicdysfunctionassociatedfattyliverdisease AT shujunshi correlationbetweenvitamindlevelandliverfibrosisinpatientswithmetabolicdysfunctionassociatedfattyliverdisease AT xuelianxiong correlationbetweenvitamindlevelandliverfibrosisinpatientswithmetabolicdysfunctionassociatedfattyliverdisease |